세계의 효소 면역측정 시장 규모, 점유율, 동향 분석 : 제품별, 용도별·시료별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Enzyme Immunoassay Market Summary

The global enzyme immunoassay market size was valued at USD 17.78 billion in 2024 and is projected to reach USD 24.77 billion by 2033, growing at a CAGR of 3.68% from 2025 to 2033. The industry growth can be attributed to the increasing demand for automation in diagnostic tests, increasing prevalence of chronic and infectious diseases, and growing awareness and use of diagnostic services.

Moreover, the growing geriatric population and increasing healthcare expenditure are also expected to drive the market growth in the coming years.According to the WHO, by the year 2050, the global population aged 60 years and above is projected to double, reaching 2.1 billion individuals. Additionally, the number of people aged 80 years or older is expected to triple from 2020 to 2050, reaching a total of 426 million.

Enzyme Immunoassay (EIA) tests are extensively used to diagnose various infectious diseases, such as HIV, hepatitis B and C, tuberculosis, and certain types of influenza. According to WHO, 630, 000 people died from HIV-related causes globally, and 39.0 million people were living with HIV at the end of 2022. Governments and health organizations across the world implement public health campaigns to encourage regular HIV testing as a key strategy in HIV prevention and control. Such initiatives increase the utilization of EIA tests and drive the market.

Technological advancements are one of the significant drivers for the enzyme immunoassay market in the field of diagnostics for infectious diseases such as HIV, hepatitis B and C, tuberculosis, and certain types of influenza. Innovations in EIA technologies have led to improvements in test sensitivity, specificity, and speed, enhancing their utility in clinical settings. For instance, the development of automated EIA systems has significantly reduced manual labor and error rates while also increasing throughput capabilities. Large-scale screening procedures are made possible by this automation, which is particularly advantageous in regions with high disease prevalence and during public health campaigns. Robotic liquid handling systems and integrated assay platforms are examples of automation technologies that improve sample throughput, decrease hands-on time, and streamline the EIA workflow. Labs can efficiently process a large number of samples and satisfy the rising demand for diagnostic testing thanks to high-throughput EIAs.

Global Enzyme Immunoassay Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global enzyme immunoassay market report based on product, application,specimen end use, and region:

• Product Outlook (Revenue, USD Billion, 2021 - 2033)
• Reagents & Kits
• Analyzers/Instruments
• Software & Services
• Application Outlook (Revenue, USD Billion, 2021 - 2033)
• Therapeutic Drug Monitoring
• Oncology
• Cardiology
• Endocrinology
• Infectious Disease Testing
• Autoimmune Diseases
• Others
• Specimen Outlook (Revenue, USD Billion, 2021 - 2033)
• Blood
• Saliva
• Urine
• Other Specimens
• End Use Outlook (Revenue, USD Billion, 2021 - 2033)
• Hospitals
• Blood Banks
• Clinical Laboratories
• Pharmaceutical and Biotech Companies
• Academic Research Centers
• Others
• Regional Outlook (Revenue, USD Billion, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. Speicmen
  • 1.2.4. End Use
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising incidence of chronic and infectious diseases
    • 3.2.1.2. Increasing demand for point-of-care diagnostics
    • 3.2.1.3. Growing demand for portable and automated immunoassays
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Lower detection limit
    • 3.2.2.2. Limitations associated with immunoassay techniques
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Enzyme Immunoassay Market: Product Business Analysis

• 4.1. Segment Dashboard
• 4.2. Global Enzyme Immunoassay Market Product Movement Analysis
• 4.3. Global Enzyme Immunoassay Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Billion)
• 4.4. Reagents & Kits
  • 4.4.1. Global Reagents & Kits Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 4.5. Analyzers/Instruments
  • 4.5.1. Global Analyzers/Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 4.6. Software & Services
  • 4.6.1. Global Software & Services Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 5. Enzyme Immunoassay Market: Application Business Analysis

• 5.1. Segment Dashboard
• 5.2. Global Enzyme Immunoassay Market Application, Movement Analysis
• 5.3. Global Enzyme Immunoassay Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Billion)
• 5.4. Therapeutic Drug Monitoring
  • 5.4.1. Global Therapeutic Drug Monitoring Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 5.5. Oncology
  • 5.5.1. Global Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 5.6. Cardiology
  • 5.6.1. Global Cardiology Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 5.7. Endocrinology
  • 5.7.1. Global Endocrinology Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 5.8. Infectious Disease Testing
  • 5.8.1. Global Infectious Disease Testing Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 5.9. Autoimmune Diseases
  • 5.9.1. Global Autoimmune Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 5.10. Others
  • 5.10.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 6. Enzyme Immunoassay Market: Specimen Business Analysis

• 6.1. Segment Dashboard
• 6.2. Global Enzyme Immunoassay Market Specimen Movement Analysis
• 6.3. Global Enzyme Immunoassay Market Size & Trend Analysis, by Specimen, 2021 to 2033 (USD Billion)
• 6.4. Blood
  • 6.4.1. Global Blood Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 6.5. Saliva
  • 6.5.1. Global Saliva Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 6.6. Urine
  • 6.6.1. Global Urine Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 6.7. Other Specimens
  • 6.7.1. Global Other Specimens Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 7. Enzyme Immunoassay Market: End Use Business Analysis

• 7.1. Segment Dashboard
• 7.2. Global Enzyme Immunoassay Market End Use Movement Analysis
• 7.3. Global Enzyme Immunoassay Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Billion)
• 7.4. Hospitals
  • 7.4.1. Global Hospitals Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 7.5. Blood Banks
  • 7.5.1. Global Blood Banks Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 7.6. Clinical Laboratories
  • 7.6.1. Global Clinical Laboratories Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 7.7. Pharmaceutical and Biotech Companies
  • 7.7.1. Global Pharmaceutical and Biotech Companies Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 7.8. Academic Research Centers
  • 7.8.1. Global Academic Research Centers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 7.9. Others
  • 7.9.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 8. Enzyme Immunoassay Market: Regional Estimates & Trend Analysis by Product, Application, Specimen & End Use

• 8.1. Regional Dashboard
• 8.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
• 8.3. North America
  • 8.3.1. North America Enzyme Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.3.2. U.S.
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Scenario
    • 8.3.2.3. Regulatory Framework
    • 8.3.2.4. U.S. Enzyme Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.3.3. Canada
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Scenario
    • 8.3.3.3. Regulatory Framework
    • 8.3.3.4. Canada Enzyme Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 8.4. Europe
  • 8.4.1. Europe Enzyme Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.4.2. UK
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. UK Enzyme Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.4.3. Germany
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Germany Enzyme Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.4.4. France
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. France Enzyme Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.4.5. Italy
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Scenario
    • 8.4.5.3. Regulatory Framework
    • 8.4.5.4. Italy Enzyme Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.4.6. Spain
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Scenario
    • 8.4.6.3. Regulatory Framework
    • 8.4.6.4. Spain Enzyme Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.4.7. Denmark
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Scenario
    • 8.4.7.3. Regulatory Framework
    • 8.4.7.4. Denmark Enzyme Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.4.8. Sweden
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Competitive Scenario
    • 8.4.8.3. Regulatory Framework
    • 8.4.8.4. Sweden Enzyme Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.4.9. Norway
    • 8.4.9.1. Key Country Dynamics
    • 8.4.9.2. Competitive Scenario
    • 8.4.9.3. Regulatory Framework
    • 8.4.9.4. Norway Enzyme Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific Enzyme Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.5.2. Japan
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Japan Enzyme Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.5.3. China
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. China Enzyme Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.5.4. India
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. India Enzyme Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.5.5. Australia
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Australia Enzyme Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.5.6. Thailand
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. Thailand Enzyme Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.5.7. South Korea
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. South Korea Enzyme Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 8.6. Latin America
  • 8.6.1. Latin America Enzyme Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.6.2. Brazil
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Brazil Enzyme Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.6.3. Mexico
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Mexico Enzyme Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.6.4. Argentina
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Competitive Scenario
    • 8.6.4.3. Regulatory Framework
    • 8.6.4.4. Argentina Enzyme Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 8.7. MEA
  • 8.7.1. MEA Enzyme Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.7.2. South Africa
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. South Africa Enzyme Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.7.3. Saudi Arabia
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. Saudi Arabia Enzyme Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.7.4. UAE
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Framework
    • 8.7.4.4. UAE Enzyme Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory Framework
    • 8.7.5.4. Kuwait Enzyme Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 9. Competitive Landscape

• 9.1. Participant Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Position Analysis, 2023
• 9.4. Participant's Overview
  • 9.4.1. Siemens Healthineers
    • 9.4.1.1. Overview
    • 9.4.1.2. Financial Performance
    • 9.4.1.3. Product Benchmarking
    • 9.4.1.4. Strategic Initiatives
  • 9.4.2. Danaher Corporation (Beckman Coulter)
    • 9.4.2.1. Overview
    • 9.4.2.2. Financial Performance
    • 9.4.2.3. Product Benchmarking
    • 9.4.2.4. Strategic Initiatives
  • 9.4.3. bioMerieux SA
    • 9.4.3.1. Overview
    • 9.4.3.2. Financial Performance
    • 9.4.3.3. Product Benchmarking
    • 9.4.3.4. Strategic Initiatives
  • 9.4.4. Sysmex Corporation
    • 9.4.4.1. Overview
    • 9.4.4.2. Financial Performance
    • 9.4.4.3. Product Benchmarking
    • 9.4.4.4. Strategic Initiatives
  • 9.4.5. QuidelOrtho Corporation.
    • 9.4.5.1. Overview
    • 9.4.5.2. Financial Performance
    • 9.4.5.3. Product Benchmarking
    • 9.4.5.4. Strategic Initiatives
  • 9.4.6. Bio-Rad Laboratories, Inc.
    • 9.4.6.1. Overview
    • 9.4.6.2. Financial Performance
    • 9.4.6.3. Product Benchmarking
    • 9.4.6.4. Strategic Initiatives
  • 9.4.7. F. Hoffmann-La Roche AG
    • 9.4.7.1. Overview
    • 9.4.7.2. Financial Performance
    • 9.4.7.3. Product Benchmarking
    • 9.4.7.4. Strategic Initiatives
  • 9.4.8. Becton, Dickinson, and Company
    • 9.4.8.1. Overview
    • 9.4.8.2. Financial Performance
    • 9.4.8.3. Product Benchmarking
    • 9.4.8.4. Strategic Initiatives
  • 9.4.9. Thermo Fisher Scientific, Inc.
    • 9.4.9.1. Overview
    • 9.4.9.2. Financial Performance
    • 9.4.9.3. Product Benchmarking
    • 9.4.9.4. Strategic Initiatives